Related Experiment Videos
[Actual considerations in pneumococcal meningitis]
1Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi Clinica de Boli Infecţioase Iaşi.
Abstract:
Streptococcus pneumoniae has been recognized as a bacterial pathogen in human beings. It was the main cause of meningitis, almost since it was first isolated by Sternberg and Pasteur more than 100 years ago. Meningitis is constantly lethal without specifically treatment. Emergence and diffusion strains of the Streptococcus pneumoniae indicate the changes that are likely in the area of antimicrobial resistance in the last decade. Resistance of Streptococcus pneumoniae to antibiotics has progressed rapidly and is a global problem. This article presents the new information about Streptococcus pneumoniae, and the new possibilities of treatment of the pneumococcal meningitis.
Insights
Streptococcus pneumoniae causes meningitis, a lethal condition. Antibiotic resistance in this bacterium is a growing global concern, necessitating new treatment strategies.
Area of Science:
- Bacteriology and Infectious Diseases
- Microbial Pathogenesis
- Epidemiology of Infectious Diseases
Context:
- Streptococcus pneumoniae is a primary bacterial cause of meningitis in humans.
- Meningitis remains a life-threatening condition without effective antimicrobial treatment.
- Recent decades show increasing prevalence and diffusion of antibiotic-resistant Streptococcus pneumoniae strains.
Purpose:
- To present updated information on Streptococcus pneumoniae.
- To explore novel therapeutic approaches for pneumococcal meningitis.
- To address the challenge of rising antimicrobial resistance.
Summary:
- This article reviews the current understanding of Streptococcus pneumoniae, a significant bacterial pathogen.
- It highlights the escalating problem of antibiotic resistance in Streptococcus pneumoniae strains.
- The review discusses emerging treatment options for pneumococcal meningitis.
Impact:
- Provides critical insights into managing pneumococcal meningitis in the face of antibiotic resistance.
- Informs clinicians and researchers about new therapeutic avenues.
- Contributes to global efforts to combat infectious disease threats.